ine

Lilly boosts immunotherapy pipeline with Armo BioSciences acquisition

The drug company will pay $1.6 billion to gain Armo’s IL-10 program




ine

Business Roundup




ine

Merck and Moderna sign cancer vaccine deal




ine

Goodbye GMO, hello BE or bioengineered




ine

Chemists elected to National Academy of Medicine




ine

Chinese chemical firms forced to stop production




ine

U.S. Army bioengineer develops high-tech fabrics to keep soldiers warm, dry, and safe

Paola D’Angelo discusses how her team develops high-performance textiles to protect and support soldiers on the battlefield




ine

Business Roundup




ine

Merck’s Ebola vaccine arrives in Congo




ine

Chemists claim they’ve defined the first new class of stereoisomers in 50 years

Akamptisomers result from bond-angle inversion




ine

Chemical firms rush to meet final REACH regulation deadline

Products made in volumes between 1 and 100 metric tons must be registered by May 31




ine

Business Roundup




ine

Chinese firm buys nylon precursor unit




ine

Deployment of Merck’s experimental Ebola vaccine well under way in the Democratic Republic of Congo

The first goal is to thwart the outbreak, but researchers also hope for new insights into combating the virus




ine

Business Roundup




ine

Avara advances in dosage form business with third buy




ine

Sadara plans pipeline for ethylene and propylene oxide




ine

PerkinElmer acquires Chinese instrument maker




ine

Alginate businesses ebb and flow




ine

At BIO convention, business boomed, and drug pricing loomed

Diversity, drug prices, and 'right to try' permeated conversation at the drug industry meeting




ine

Business Roundup




ine

Ineos progresses plans for U.S. ethylene oxide plant




ine

Flow system turns amines into alcohols efficiently

Closed-loop flow process uses concentrated catalysts and recycles cofactors to improve conversion




ine

Engineered cotton grows on alternative fertilizer

Crop feeds on phosphite, potentially allowing it to outwit weeds and mitigate pollution from traditional fertilizer runoff




ine

Business Roundup




ine

Sanofi and Translate Bio to make mRNA vaccines for infectious diseases




ine

Engineered cotton grows on alternative fertilizer

Crop feeds on phosphite, potentially allowing it to outwit weeds and mitigate pollution from traditional fertilizer runoff




ine

Slime-making craze has become a big business

Glue and borax sales have been brisk as kids and parents look for do-it-yourself activities




ine

Ineos Styrolution invests in France




ine

Roche pays $2.4 billion for rest of Foundation Medicine




ine

Some Chinese power plants may underreport sulfur dioxide emissions

Data from air pollution monitors don’t jibe with satellite measurements




ine

Polymer strips off-taste from wine

Magnetic property enables easy separation of sorption medium




ine

Business Roundup




ine

Gene therapy start-up Freeline Therapeutics raises $116 million




ine

Business Roundup




ine

BASF taps Citrine for artificial intelligence




ine

Meet <i>Science</i> magazine editor Jeremy Berg, chemist and proud data wonk

Policy leader talks about publishing, the scientific enterprise, and how chemistry fits into it all




ine

Call for papers for fluorine conference




ine

Dow fined $1.7 million over perks for CEO Liveris




ine

AkzoNobel upgrading Rotterdam chlorine




ine

Business Roundup




ine

Ineos to build first European cracker in 20 years




ine

U.S. Supreme Court nominee Brett Kavanaugh likely to limit regulatory authority

Current district judge is viewed as reliably conservative, deferent to presidential power




ine

U.S. considers tariffs on more Chinese chemicals

Numerous basic inputs may be hit with a 10% import tax as trade war intensifies




ine

U.K. builds center in Scotland for medicine production




ine

Business Roundup




ine

South Korea’s SK to acquire Ampac Fine Chemicals




ine

Chemists fracture rings to install fluorine

Reaction opens unstrained nitrogen rings furnishing alkyl fluorine compounds




ine

Sanofi pays $50 million for Revolution Medicines’ SHP2 inhibitor

The partners expect to begin clinical studies of the compound later this year




ine

Verge Genomics raises $32 million for machine learning-backed neuroscience drug discovery